Embargo Policy for TCT® 2025
Please note that press conference presentations of late-breaking clinical trials and science at TCT are held prior to the official presentations as a courtesy to the media. Embargoes do not lift until the start time of each individual trial presentation, as listed in the TCT program. All embargo times are listed in Pacific Time (PT). This schedule is subject to change.
Sunday, October 26, 2025
8:00 AM - 9:38 AM PT
8:00 AM
One-Year Results of the SELUTION DeNovo Trial Comparing a Strategy of PCI with a Sirolimus-eluting Balloon and Provisional Stenting Versus Systematic DES Implantation to Treat DeNovo Coronary Lesions
Christian M. Spaulding, MD, PhD
Embargo Lift Time: 10/26; 11:00 AM PT
8:12 AM
Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis
Donald Cutlip, MD
Embargo Lift Time: 10/26; 11:22 AM PT
8:24 AM
Randomized Comparison of Intravascular Lithotripsy vs. Cutting Balloon Treatment in Calcified Coronary Artery Disease – The Short-CUT Trial
Suzanne J. Baron, MD, MSc
Embargo Lift Time: 10/26; 11:44 AM PT
8:36 AM
A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial
Matthias Bossard, MD
Embargo Lift Time: 10/26; 12:06 PM PT
8:48 AM
Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE
Robert A. Lookstein, MD
Embargo Lift Time: 10/26; 2:00 PM PT
8:58 AM
Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions
Sahil A. Parikh, MD
Embargo Lift Time: 10/26; 2:18 PM PT
9:08 AM
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Josep Rodés-Cabau, MD, PhD
Embargo Lift Time: 10/26; 2:36 PM PT
9:18 AM
Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry
Rahul Prakash Sharma, MD
Embargo Lift Time: 10/26; 2:54 PM PT
9:28 AM
Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial
Jonathan G. Schwartz, MD
Embargo Lift Time: 10/26; 3:12 PM PT
Monday, October 27, 2025
8:00 AM – 9:38 AM ET
8:00 AM
Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study
David J. Cohen, MD
Embargo Lift Time: 10/27; 11:00 AM PT
8:12 AM
Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes
Michael J. Mack, MD
Embargo Lift Time: 10/27; 11:22 AM PT
8:24 AM
Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort
Paul Sorajja, MD
Embargo Lift Time: 10/27; 11:44 AM PT
8:36 AM
Percutaneous Transseptal Transcatheter Mitral Valve Replacement using a Dedicated Balloon Expandable Valve: 1 Year Outcomes from the ENCIRCLE Trial using the SAPIEN M3
David Daniels, MD
Embargo Lift Time: 10/27; 12:06 PM PT
8:48 AM
Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial
David Erlinge, MD, PhD
Embargo Lift Time: 10/27; 2:00 PM PT
8:58 AM
Comparison of Drug-Coated Versus Conventional Balloons for Treatment of Side Branches of Bifurcation Lesions: The OCVC-BIF Study
Takayuki Ishihara, MD
Embargo Lift Time: 10/27; 2:18 PM PT
9:08 AM
Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial
Lei Song, MD
Embargo Lift Time: 10/27; 2:36 PM PT
9:18 AM
Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial
Chao Gao, MD, PhD
Embargo Lift Time: 10/27; 2:54 PM PT
9:28 AM
Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial
Evald H. Christiansen, MD, PhD
Embargo Lift Time: 10/27; 3:12 PM PT
Tuesday, October 28, 2025
8:00 AM – 9:50 AM PT
8:00 AM
Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery (PROCTOR): A Multicenter, Open-label, Randomized Trial
Ruben W. de Winter, MD
Embargo Lift Time: 10/28; 11:00 AM PT
8:12 AM
Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Ajunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial
Shamir R. Mehta, MD, MSc
Embargo Lift Time: 10/28; 11:18 AM PT
8:24 AM
Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions in Patients with Acute ST-Elevation Myocardial Infarction: A Randomized Superiority Trial
Robin Nijveldt, PhD, MD
Embargo Lift Time: 10/28; 11:36 AM PT
8:36 AM
Stratified Treatment of Myocardial Infarction with Non-Obstructive Coronary Arteries: The PROMISE Trial
Rocco Antonio Montone, MD, PhD
Embargo Lift Time: 10/28; 11:54 AM PT
8:48 AM
Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial
Upendra Kaul, MD
Embargo Lift Time: 10/28; 12:12 PM PT
9:00 AM
iFR Versus Angiography-Guided CABG: 3-Year Results of the iCABG Randomized Trial
Rasa Ordiene, MD, PhD
Embargo Lift Time: 10/28; 2:00 PM PT
9:10 AM
Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial
Patrick W. Serruys, MD, PhD
Embargo Lift Time: 10/28; 2:18 PM PT
9:20 AM
A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Novel Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention
Rui Wang, MD
Embargo Lift Time: 10/28; 2:36 PM PT
9:30 AM
The Effectiveness and Safety of a Planned Investment Procedure in High-Risk Chronic Total Occlusions - The INVEST CTO Single Arm Study
Anja Oksnes, MD
Embargo Lift Time: 10/28; 3:12 PM PT
9:40 AM
AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry
Timothy D. Henry, MD
Embargo Lift Time: 10/28; 2:54 PM

